Shortage of a Protein Linked to Autism in Mice

Mice born with lower amounts of nSR100 protein display the symptoms of autism spectrum disorder, suggesting a functional link.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, AARON LOGANMice born with normal levels of nSR100 protein appear just fine, and those born with none of the protein tend to die. But according to a December 15 study in Molecular Cell, mice born with a shortage of nSR100 display many of the symptoms of autism spectrum disorder. The study suggests that nSR100 shortage may account for as many as 33 percent of autism cases in mice. “We’ve really hit upon a common mechanism that may account for at least one third of autism spectrum disorder cases,” coauthor Benjamin Blencowe of the University of Toronto told The Globe and Mail.

Blencowe and colleagues first came across nSR100 in 2014, when they discovered that the protein was a key regulator of alternative splicing, a system that cells—especially those in the brain—use to tweak how DNA produces proteins. Subsequent studies revealed that nSR100 levels tend to be lower in the postmortem brain tissue of people with autism. For the present study, Blencowe and colleagues have demonstrated, for the first time, that mice born with low levels of nSR100 in their brain cells indeed display many of the symptoms of autism, including hypersensitivity to environment and impaired sociability.

By studying individual mouse brain cells, the team also determined that any mutation that increases neuronal excitability often leads to lower levels of nSR100 in the cell, a finding that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Joshua A. Krisch

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours